Historical salary details - Mr. Richard Scott Huennekens, Executive Chairperson of the Board, Hyperfine Inc - Ordinary Shares - Class A
Mr. Richard Scott Huennekens is the Executive Chairperson of the Board of Hyperfine Inc - Ordinary Shares - Class A. They also hold 1 other positions in and NeuroPace Inc.
Mr. Richard Scott Huennekens
Executive Chairperson of the Board
-
Gross Remuneration
-
Current Company
Hyperfine Inc - Ordinary Shares - Class A
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2025 | Hyperfine Inc - Ordinary Shares - Class A | Executive Chairperson of the Board | - | - |
| 2025 | NeuroPace Inc | Director | - | - |
| 2024 | Envista Holdings Corp | Chairman of the Board | 435.0 K | -0.0 % |
| 2024 | Hyperfine Inc - Ordinary Shares - Class A | Executive Chairperson of the Board | 158.9 K | - |
| 2024 | QuidelOrtho Corporation | Independent Director | 96.4 K | - |
| 2024 | NeuroPace Inc | Director | - | - |
| 2024 | Acutus Medical Inc | Chairman of the Board | - | - |
| 2023 | Envista Holdings Corp | Chairman of the Board | 435.1 K | 5.7 % |
| 2022 | Envista Holdings Corp | Chairman of the Board | 411.6 K | 3.4 % |
| 2022 | Acutus Medical Inc | Chairman of the Board | 181.1 K | 49.7 % |
| 2022 | Hyperfine Inc - Ordinary Shares - Class A | Executive Chairman of the Board | - | - |
| 2021 | Hyperfine Inc - Ordinary Shares - Class A | Executive Chairman of the Board | 2.7 M | - |
| 2021 | Envista Holdings Corp | Chairman of the Board | 398.1 K | 2.0 % |
| 2021 | Acutus Medical Inc | Chairman of the Board | 121 K | -32.6 % |
| 2020 | Envista Holdings Corp | Chairman of the Board | 390.4 K | 60.8 % |
| 2020 | Acutus Medical Inc | Executive Chairman of the Board | 179.4 K | -97.7 % |
| 2020 | Hyperfine Inc - Ordinary Shares - Class A | Executive Chairman of the Board | - | - |
| 2019 | Acutus Medical Inc | Executive Chairman of the Board | 7.9 M | - |
| 2019 | Envista Holdings Corp | Chairman of the Board | 242.8 K | - |
| 2018 | Envista Holdings Corp | Chairman of the Board | - | - |
| 2015 | Bellerophon Therapeutics Inc | - | 170.5 K | - |
| 2015 | Bellerophon Therapeutics Inc | Independent Director | - | - |